| Investigator | Title | Sponsor | ID | Dates | Amount | 
        
            | Peter Matthew Kennedy de Blank, MD | Children's Tumor Foundation Ne | The Children's Tumor Foundation | CTF, DeBlank, P. | 1/1/22-12/31/22 | $150 | 
        
            | Rajaram Nagarajan, MD | Research Into Visual Endpoints | National Institutes of Health (NIH)/Vanderbilt University Medical Center | VUMV67585 | 8/1/21-7/31/22 | $4,000 | 
        
            | Peter Matthew Kennedy de Blank, MD | NF110: Open-label, Phase 2 Cli | Department of Defense/The Board of Trustees of the University | 000516840-T002-SC004 | 4/23/20-8/15/21 | $4,340 | 
        
            | Kaylin G Earnest, PHD | Training grant | National Institutes of Health (NIH)/University of Cincinnati | 1015348 | 9/1/20-8/31/21 | $5,410 | 
        
            | Karen C Burns, MD | Fertility Status Assessment Am | National Institutes of Health (NIH)/Emory University | A567559 | 9/15/21-7/31/22 | $5,852 | 
        
            | James Geller, MD | Study Chair | National Institutes of Health (NIH)/Public Health Institute | AR03451 | 3/1/21-2/28/22 | $7,833 | 
        
            | James Geller, MD | Study Chair AREN 1721 2021 | National Institutes of Health (NIH)/Public Health Institute | AR03450 | 3/1/21-2/28/22 | $7,833 | 
        
            | Robin E Norris, MD-MPH | NCTN Renal Committee Retreat | National Institutes of Health (NIH)/Public Health Institute | AR04978 | 3/1/21-2/28/22 | $8,000 | 
        
            | Peter Matthew Kennedy de Blank, MD | Biomarker, Imaging and Quality | National Institutes of Health (NIH)/Public Health Institute | AR04810 | 3/1/21-2/28/22 | $8,080 | 
        
            | Christine L Phillips, MD | Asparaginase premedication, hy | Childrens Hospital of Orange County | Phillips, C, CHOC | 12/1/21-11/30/22 | $8,470 | 
        
            | Maureen O'Brien, MD | Scientific Advisor Board Service | Alex's Lemonade Stand Foundation | O'Brien, Maureen ALS | 12/1/21-11/30/22 | $10,000 | 
        
            | Lisa Marie Privette Vinnedge, PHD | Functional Role of DEK in Alzh | Life Sciences Research Foundation/University of Cincinnati | LIFE FND 2019 | 11/1/20-10/31/22 | $10,500 | 
        
            | Teresa S. Latham | SU2C Catalyst Grant | Stand Up to Cancer/Nationwide Children's Hospital | SU2C 6147 | 7/1/20-8/31/21 | $12,375 | 
        
            | Trent Hummel, MD | Targeting epigenetic dysregula | Stand Up to Cancer/Dana Farber Cancer Institute | 6332101 | 1/1/22-12/31/22 | $13,567 | 
        
            | Biplab DasGupta, PHD | Therapeutic resistance and agg | National Institute for Health Research/University of Cincinnati | 013734-00002 | 7/1/21-6/30/22 | $14,324 | 
        
            | James Geller, MD | Study Chair | National Institutes of Health (NIH)/Public Health Institute | AR03426 | 3/1/21-2/28/22 | $15,665 | 
        
            | William Seibel, PHD | Structure, function, and modul | National Institutes of Health (NIH)/The University of Chicago | AWD102456SUB00000571 | 9/30/21-7/31/22 | $18,268 | 
        
            | Peter Matthew Kennedy de Blank, MD | CHOP-COG ACN1833 | Matthew Larson Pediatric Brain Tumor Fdn/Children's Hospital of Philadelphia | ACNS1833 | 8/1/21-7/31/26 | $18,958 | 
        
            | Biplab DasGupta, PHD | Co-targeting S6 and TAM kinas | National Institutes of Health (NIH)/University of Cincinnati | 12653-002 | 12/1/21-11/30/22 | $19,467 | 
        
            | Rajaram Nagarajan, MD | Research Into Visual Endpoints | National Institutes of Health (NIH)/Vanderbilt University Medical Center | VUMV67585 | 8/1/21-7/31/22 | $22,397 | 
        
            | Peter Matthew Kennedy de Blank, MD | Study Chair | National Institutes of Health (NIH)/Public Health Institute | AR03413 | 3/1/21-2/28/22 | $23,498 | 
        
            | Maureen O'Brien, MD | O'Brien PHI-COG Study Chair AALL1732 2021 | National Institutes of Health (NIH)/Public Health Institute | : AR03402 | 3/1/21-2/28/22 | $23,499 | 
        
            | Robin E Norris, MD-MPH | A Phase 2 Randomized Trial of | National Institutes of Health (NIH)/Children's Hospital Los Angeles | T2020-003 | 9/14/21-8/31/26 | $26,000 | 
        
            | Robin E Norris, MD-MPH | Norris PHI-COG Associate Medic | National Institutes of Health (NIH)/Public Health Institute | AR03186 | 3/1/21-2/28/22 | $31,330 | 
        
            | Robin E Norris, MD-MPH | PHI-COG PCR Work Order 2021 | National Institutes of Health (NIH)/Public Health Institute | Norris_R._PHI/NIH | 3/1/21-2/28/25 | $34,004 | 
        
            | Robin E Norris, MD-MPH | PHI-COG NCTN Work Order 2021 | National Institutes of Health (NIH)/Public Health Institute | U10CA180886 | 3/1/21-2/28/25 | $34,004 | 
        
            | Brian Keith Turpin, DO | SARC038:  A Phase 2 Study of R | Sarcoma Alliance for Res through Collabo | SARC038 | 10/1/21-9/30/26 | $36,250 | 
        
            | Robin E Norris, MD-MPH | Norris PHI-COG PEP-CTN WLI Core Work Order | National Institutes of Health (NIH)/Public Health Institute | AR06748 | 8/1/21-7/31/23 | $40,627 | 
        
            | Joseph Pressey, MD | Norris PHI-COG PEP-CTN PCR Work Order | National Institutes of Health (NIH)/Public Health Institute | AR06748 | 8/1/21-7/31/23 | $40,779 | 
        
            | John P Perentesis, MD | A Phase I study of Venetoclax | Conquer Cancer Foundation/Michigan State University | RC111290 CHMC | 7/1/20-6/30/22 | $46,500 | 
        
            | Robin E Norris, MD-MPH | Norris PHI-COG NCORP PCR Work Order 2021 | National Institutes of Health (NIH)/Public Health Institute | UG1CA189955-08 | 8/1/21-7/31/25 | $47,504 | 
        
            | Robin E Norris, MD-MPH | Norris PHI-COG NCORP PCR Work Order 2021 | National Institutes of Health (NIH)/Public Health Institute | UG1CA189955-08 | 8/1/21-7/31/25 | $47,504 | 
        
            | Natasha Pillay-Smiley, DO | The Pediatric Brain Tumor Cons | National Institutes of Health (NIH)/St Jude's Children's Hospital | 110068220-7998047 | 4/1/21-3/31/22 | $49,920 | 
        
            | Natasha Pillay-Smiley, DO | The Pediatric Brain Tumor Cons | National Institutes of Health (NIH)/St Jude's Children's Hospital | 110068210-7947557 | 4/1/21-3/31/22 | $49,920 | 
        
            | Alexandra Power-Hays, MD | ADAPT- Alternate Dosing And Pr | American Society of Hematology | ASH_Power Hays | 7/1/21-6/30/22 | $50,000 | 
        
            | Natasha Pillay-Smiley, DO | Understanding Chemotherapy Failure in AML: Resistance Mechanisms to a Nanoparticle Chemotherapy Delivery System | National Institutes of Health (NIH)/Children's Hospital of Philadelphia | U10CA180886 | 3/1/20-2/28/21 | $50,000 | 
        
            | John P Perentesis, MD | Investigating the role of ovar | Cancer Free Kids | Absalon/Grimes_Cance | 12/1/17-12/31/21 | $50,000 | 
        
            | Lisa Marie Privette Vinnedge, PHD | COG Autopsy Initiative | Cancer Free Kids | Johnstone, M., CFK | 7/1/20-6/30/23 | $50,000 | 
        
            | Biplab DasGupta, PHD | One carbon and nucleotide meta | Cancer Free Kids | CFK, Dasgupta, D. | 1/1/22-6/30/23 | $50,000 | 
        
            | Biplab DasGupta, PHD | Therapeutic Blockade of Metabo | Team Connor Childhood Cancer Foundation | TCCCF, Dasgupta, B. | 1/1/22-12/31/22 | $50,000 | 
        
            | Emily L Duderstadt, PHD | Training Grant | National Institutes of Health (NIH)/University of Cincinnati | 1016448 | 9/1/21-2/11/22 | $52,704 | 
        
            | Natasha Pillay-Smiley, DO | PBTC-060: A Pilot Study of Saf | National Institutes of Health (NIH)/St Jude's Children's Hospital | Pillay-Smiley, St Ju | 3/1/22-2/28/27 | $59,320 | 
        
            | Natasha Pillay-Smiley, DO | Phase 1 Trial of Autologous HE | National Institutes of Health (NIH)/St Jude's Children's Hospital | PBTC-059 | 1/1/22-12/31/26 | $59,320 | 
        
            | John P Perentesis, MD | Children's Oncology Group Pedi | National Institutes of Health (NIH)/Children's Hospital of Philadelphia | SUB23 01 | 8/1/19-7/31/20 | $60,001 | 
        
            | Lynn H Lee, MD | Targeting MBNL1-mediated alter | St. Baldrick's Foundation | AwardID: 638749 | 7/1/21-6/30/22 | $63,190.51 | 
        
            | Brenton Francisco, MD | A multicenter open-label study | Hyundai Hope on Wheels | HHOW | 7/1/21-6/30/22 | $100,000 | 
        
            | Brian D Weiss, MD | A multicenter open-label study | Advanced Accelerator Applications, Inc. | CAAA601A32201 | 8/1/21-7/30/26 | $86,404 | 
        
            | Alexandra Power-Hays, MD | Alternative Dosing And Prevent | Doris Duke Charitable Foundation | 2021097 | 7/1/21-6/30/22 | $110,000 | 
        
            | Susanne Wells, PHD | P50 SPORE Pilot project #4 Max | National Institutes of Health (NIH)/University of Cincinnati Cancer Center | 4600003138 | 4/1/21-11/30/22 | $106,540 | 
        
            | LaQuita M Jones, DO | Kinase-independent mechanism o | St. Baldrick's Foundation | 839526 | 7/1/21-6/30/22 | $110,000 | 
        
            | Francis R LeBlanc, MD-PHD | Defining genetic and metabolic | National Institutes of Health (NIH)/Cornell University | 215518-2 | 7/1/21-6/30/22 | $119,880 | 
        
            | Peter Matthew Kennedy de Blank, MD | The Neurofibromatosis Clinical | Department of Defense Army/University of Alabama-Birmingham | 000516840-SC004 | 8/15/21-8/14/22 | $128,235 | 
        
            | Susanne Wells, PHD | Defining genetic and metabolic | National Institutes of Health (NIH)/University of Cincinnati | 012828-002 | 4/1/21-3/31/22 | $170,000 | 
        
            | Lynn H Lee, MD | Targeting MBNL1-mediated alter | National Institutes of Health (NIH) | K08CA237753 | 3/1/22-2/28/23 | $196,112 | 
        
            | Biplab DasGupta, PHD | Targeting Purine Synthesis and | The Cure Starts Now Foundation | CSNF_Dasgupta, B. | 10/1/21-9/30/22 | $200,000 | 
        
            | Lisa Marie Privette Vinnedge, PHD | Mechanisms coupling DEK to oncogenesis | National Institutes of Health (NIH) | R01CA218072 | 2/1/22-1/31/23 | $327,341 | 
        
            | Susanne Wells, PHD | Strenghening epidermal defense | National Institutes of Health (NIH) | R01CA228113 | 12/1/21-11/30/22 | $334,853 | 
        
            | Susanne Wells, PHD | New activities of the human DE | National Institutes of Health (NIH) | R01CA239605 | 12/1/21-11/30/22 | $355,127 | 
        
            | Susanne Wells, PHD | FA pathway activities in norma | National Institutes of Health (NIH) | R01CA223790 | 8/1/21-7/31/22 | $363,713 | 
        
            | Biplab DasGupta, PHD | Bystander gene deletions in ca | National Institutes of Health (NIH) | R01NS114074 | 12/1/21-11/30/22 | $435,338 | 
        
            | Biplab DasGupta, PHD | Mechanisms of Biguanide Sensit | National Institutes of Health (NIH) | R01NS099162 | 5/1/22-4/30/23 | $504,183 | 
        
            | Trent Hummel, MD | International Diffuse Intrinsi | The Cure Starts Now Foundation | Dewire, DIPG | 12/10/20-12/9/21 | $1,508,203 | 
        
            | Total Annual Grant Award Dollars | $6,497,292.51 |